Xu W, Ma Y, Ma H, Shi L, Mu H, Ou W, et al. Co-targeting CK2α and YBX1 suppresses tumor progression by coordinated inhibition of the PI3K/AKT signaling pathway. Cell Cycle. 2019;18:3472-3490 pubmed publisher

Yang F, Zuo Y, Zhou W, Xia C, Hahm B, Sullivan M, et al. sNASP inhibits TLR signaling to regulate immune response in sepsis. J Clin Invest. 2018;128:2459-2472 pubmed publisher

Turowec J, Duncan J, French A, Gyenis L, St Denis N, Vilk G, et al. Protein kinase CK2 is a constitutively active enzyme that promotes cell survival: strategies to identify CK2 substrates and manipulate its activity in mammalian cells. Methods Enzymol. 2010;484:471-93 pubmed publisher